Familial hypercholesterolemia: current treatment and advances in management.
about
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis SocietySubjects with molecularly defined familial hypercholesterolemia or familial defective apoB-100 are not being adequately treatedQuality assessment of the genetic test for familial hypercholesterolemia in the Netherlands.Two years after molecular diagnosis of familial hypercholesterolemia: majority on cholesterol-lowering treatment but a minority reaches treatment goal.Common genetic variants do not associate with CAD in familial hypercholesterolemia.Mutation in KERA identified by linkage analysis and targeted resequencing in a pedigree with premature atherosclerosis.Metabolic syndrome, dyslipidemia, hypertension and type 2 diabetes in youth: from diagnosis to treatment.Hypercholesterolemia and microvascular dysfunction: interventional strategies.Optimal management of familial hypercholesterolemia: treatment and management strategiesFounder mutations in the Netherlands: geographical distribution of the most prevalent mutations in the low-density lipoprotein receptor and apolipoprotein B genesGenome-wide association studies in atherosclerosisPlasma levels of PCSK9 and phenotypic variability in familial hypercholesterolemia.Improved access to life insurance after genetic diagnosis of familial hypercholesterolaemia: cross-sectional postal questionnaire study.Adeno-associated virus serotype 8 gene therapy leads to significant lowering of plasma cholesterol levels in humanized mouse models of homozygous and heterozygous familial hypercholesterolemia.A rare variant in MCF2L identified using exclusion linkage in a pedigree with premature atherosclerosisFamilial hypercholesterolemia and the atherosclerotic disease.Inherited metabolic disorders and cerebral infarction.Type of LDLR mutation and the pharmacogenetics of familial hypercholesterolemia treatment.Autosomal recessive hypercholesterolaemia in a Morrocan family due to a mutation of the G266C LDL receptorNew Treatments on the Horizon for Familial Hypercholesterolemia.Implementing genome-driven personalized cardiology in clinical practice.SLCO1B1 haplotypes are not associated with atorvastatin-induced myalgia in Brazilian patients with familial hypercholesterolemia.
P2860
Q27024882-656C60E5-A2B0-4CB9-AFD6-B11CF915BD32Q28477200-88AA512A-2DBA-4D6C-904D-E31BE719686FQ30541806-A8FAB4DA-D10C-4E62-8B34-121FC128EB30Q33532632-674E17B7-BE55-46F2-9CF4-CB2CE2635627Q33620844-1648F901-EF80-4626-8548-4886AD31F339Q33690049-313A87AA-6491-49C8-9758-5509633462DFQ34128192-1E763951-5825-4047-BCBC-27F2DEE9A9B0Q34375542-D781EB13-4798-4448-8D28-6E91190DFBEFQ34417480-B1C2EEA4-9D05-4D1F-86C2-42333B5CBC71Q34679770-E20A5D5B-B3A5-4099-96E5-2F91A2196BF9Q34902005-992C0938-9C82-49AA-80D3-AE6E4A1ECACCQ35897064-DD7EF2AE-7956-4F38-B981-DDA62444A0E2Q36035727-79AE9F78-33FE-49D3-B140-9AAB7C4A6E71Q36562652-8A543BB1-17E2-4BB9-B3C2-36489B2051FDQ36695830-1C374CDF-7C76-409A-A969-8525C39DB256Q37029808-C1D1AA5D-0B13-4393-B623-916C8233246CQ37318161-DCDCAE94-97F5-4FA8-9BF9-EE1633F45B62Q38596963-E1CCC6E7-861F-49D6-B97E-5353283AC3FCQ38984149-4D341000-1B0E-4147-8B84-9500C2DF1B1EQ47098216-5DFD130F-60D0-4028-9745-C820FE49D00EQ49990965-39D7E304-B99F-4F54-A151-126DCF1D798AQ54559255-16EF2F5B-98BB-40CE-81F3-42FDBECD5BCE
P2860
Familial hypercholesterolemia: current treatment and advances in management.
description
2008 nî lūn-bûn
@nan
2008 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Familial hypercholesterolemia: current treatment and advances in management.
@ast
Familial hypercholesterolemia: current treatment and advances in management.
@en
Familial hypercholesterolemia: current treatment and advances in management.
@nl
type
label
Familial hypercholesterolemia: current treatment and advances in management.
@ast
Familial hypercholesterolemia: current treatment and advances in management.
@en
Familial hypercholesterolemia: current treatment and advances in management.
@nl
prefLabel
Familial hypercholesterolemia: current treatment and advances in management.
@ast
Familial hypercholesterolemia: current treatment and advances in management.
@en
Familial hypercholesterolemia: current treatment and advances in management.
@nl
P2093
P2860
P356
P1476
Familial hypercholesterolemia: current treatment and advances in management.
@en
P2093
Barbara A Hutten
Joep C Defesche
John J P Kastelein
Maud N Vissers
Peter J Lansberg
Roeland Huijgen
P2860
P304
P356
10.1586/14779072.6.4.567
P577
2008-04-01T00:00:00Z